Hormone Receptor and c-ERBB2 Status in Distant Metastatic and Locally Recurrent Breast Cancer
- 1 March 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 133 (3), 416-429
- https://doi.org/10.1309/ajcpj57flljrxkpv
Abstract
Estrogen receptor (ER), progesterone receptor (PR), and c-ERBB2 (HER2/neu) are therapeutically and prognostically important markers in the management of breast carcinoma. They are not always analyzed in distant metastatic and locally recurrent breast cancers. We compared immunohistochemical expression in a series of primary breast carcinomas with their distant metastases (n = 72) and local recurrences (n = 45) and analyzed the impact of any changes on survival. Discordance rates between primary and metastatic and between primary and locally recurrent lesions, respectively, were 18% (13/72) and 13% (6/45) for ER, 42% (30/72) and 33% (15/45) for PR, and 7% (5/72) and 2% (1/45) for c-ERBB2. There was statistically significant discordance between primary and metastatic PR status (P = .017; κ = 0.201). Among locally recurrent tumors, 15 (33%) of 45 revealed discordance for PR (P = .006; κ = 0.366). We observed a trend for shorter survival among women with ER– metastatic and locally recurrent tumors regardless of the primary tumor ER status. Our findings suggest a benefit for routine evaluation of ER, PR, and c-ERBB2 status in distant metastatic and locally recurrent breast cancer for therapeutic and prognostic purposes.Keywords
This publication has 43 references indexed in Scilit:
- Estrogen Receptor Analysis for Breast CancerAdvances in Anatomic Pathology, 2005
- Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parametersPathology, 2001
- The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for TherapyThe International Journal of Cell Cloning, 1998
- Estrogen Receptor Determinations of Cutaneous Recurrences of Breast Cancers: Reduced Sensitivity of Hormone Binding AssaysThe Breast Journal, 1995
- c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast CancerNew England Journal of Medicine, 1994
- Hormones and breast cancerTrends in Endocrinology & Metabolism, 1991
- The value of estrogen and progesterone receptors in the treatment of breast cancerCancer, 1980
- The clinical value of multiple steroid receptor assays in breast cancer managementCancer, 1980
- Estrophilin assays in breast cancer: Quantitative features and application to the mastectomy specimenCancer, 1980
- Factors affecting estrogen receptors in breast cancerCancer, 1977